Although circulating fetuin-A levels are generally elevated in patients with NAFLD, its levels in patients with liver fibrosis remains controversial [38], and a negative correlation has been observed between circulating fetuin-A and the severity of liver fibrosis [39, 40]. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.